Home›Stock Screener›Parmax Pharma›P/B Ratio

Parmax Pharma P/B Ratio

Current P/B Ratio
-6.55
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity

Parmax Pharma P/B ratio. Parmax Pharma (PARMAX) P/B ratio is -6.55 (Low), book value per share ₹-15.00 vs Healthcare average P/B of 0.16 — Very Low - Significant discount to book value, potential distress or value opportunity. View PARMAX 52-week performance for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio -6.55
Current Price ₹137.75
Book Value/Share ₹-15.00
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹-6 Cr
Share Capital ₹4 Cr
Reserves & Surplus ₹-11 Cr
Outstanding Shares 4,000,000
Book Value per Share ₹-15.00

Valuation Signal

Signal Undervalued
Historical Avg 2.97
Historical Range 2.71 - 3.23
Percentile 0.0%

Sector Context

Sector Average 0.16
Sector Median 0.67
Sector Rank #1 of 50
Sector Percentile 2.0%

PARMAX P/B Ratio — Valuation Insights & Book Value Analysis

Parmax Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B -6.55 (Low). For live price, earnings yield and the full fundamental profile, see PARMAX screener.

  • Stock appears undervalued with PB of -6.55, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Current PB is 320.5% below historical average
  • Trading at discount to sector average PB of 0.16

Parmax Pharma P/B Ratio Historical Trend

PARMAX annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse PARMAX institutional holdings to track promoter, FII and institutional holdings.

PARMAX Historical P/B Ratio — Book Value Per Share & Year-End Price

Parmax Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2023 2.71 ₹12.0 ₹32.57 ₹6 Moderate
2022 3.23 ₹12.0 ₹38.70 ₹6 High

PARMAX vs Healthcare Peers — P/B Ratio Comparison

Parmax Pharma P/B -6.55 vs Healthcare average 0.16, median 0.67 — range -6.32–1.16.

Sector Average
0.16
Sector Median
0.67
Lowest P/B
-6.32
Highest P/B
1.16
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹35 Low
Krebs Biochemicals & Ind… KREBSBIO -0.8 ₹147 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.19 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low
Dipna Pharmachem DPL 0.19 ₹12 Low